Martin Ullmann results 14
· Newest (Page 1/1, per page 25)
Author: Martin Ullmann ×Clear All Filters
Search Results
Local and Landscape‐Level Environmental Conditions Drive Habitat Selection Across Terrestrial Mammal SpeciesNARA Subscribed
Aim Animal movements are a fundamental process affecting communities and ecosystems. Quantifying habitat selection across species and habitats is key for understanding how animals respond to environmental change. Currently, we lack comparative studies that examine how habitat selection varies across species traits and landscapes. We aim to quantify global patterns of habitat selection to help understand the fundamental drivers...
Climate change information tailored to the agricultural sector in Central Europe, exemplified on the region of Lower FranconiaNARA Subscribed
There is a growing societal, economic, and political demand to translate available data on regional climate change into sector-specific, practice-oriented, and user-friendly information. The study presents a demand-driven approach to specify the impacts of regional climate change on agriculture, viticulture, and fruit and vegetable growing in Lower Franconia, southern Germany, a region with heterogeneous topography, diversifie...
Evaluating expert‐based habitat suitability information of terrestrial mammals with GPS‐ tracking dataNARA Subscribed
Aim Macroecological studies that require habitat suitability data for many species often derive this information from expert opinion. However, expert‐based information is inherently subjective and thus prone to errors. The increasing availability of GPS tracking data offers opportunities to evaluate and supplement expert‐based information with detailed empirical evidence. Here, we compared expert‐based habitat suitability info...
The determination of a tailored anti-drug antibody (ADA) testing strategy is based on the immunogenicity risk assessment to allow a correlation of ADAs with changes to pharmacokinetics, efficacy, and safety. The clinical impact of ADA formation refines the immunogenicity risk assessment and defines appropriate risk mitigation strategies. Health agencies request for high-risk biotherapeutics to extend ADA monitoring for patient...
Previous1Next